Home » Companies
AstraZeneca PLC (LON:AZN) Receives Average Rating of “Moderate Buy” from Brokerages
AstraZeneca PLC (LON:AZN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the nine brokerages that are currently covering the firm, Marketbeat reports. One research analyst has rated the... More of this article »
FY2024 Earnings Forecast for IN8bio Issued By HC Wainwright
IN8bio, Inc. (NASDAQ:INAB – Free Report) – HC Wainwright issued their FY2024 earnings per share (EPS) estimates for IN8bio in a note issued to investors on Wednesday, November 13th. HC Wainwright analyst S. Ramakanth... More of this article »
FY2024 EPS Estimates for Opus Genetics Cut by HC Wainwright
Opus Genetics, Inc. (NASDAQ:IRD – Free Report) – Analysts at HC Wainwright reduced their FY2024 earnings estimates for shares of Opus Genetics in a research report issued to clients and investors on Wednesday, November... More of this article »
Okta (NASDAQ:OKTA) Downgraded by Deutsche Bank Aktiengesellschaft to “Hold”
Deutsche Bank Aktiengesellschaft lowered shares of Okta (NASDAQ:OKTA – Free Report) from a buy rating to a hold rating in a research note published on Tuesday, MarketBeat Ratings reports. The brokerage currently has $85.00 price... More of this article »
Southport Acquisition Corporation Reports Results of Special Meeting and Amendments to Charter
Southport Acquisition Corporation (NYSE:PORT) recently announced the outcomes of its special meeting of stockholders held on November 13, 2024. At the meeting, stockholders voted on important proposals and amendments that have implications... More of this article »
James River Group Holdings, Ltd. Enters into Multiple Agreements in Connection with Preferred Shares and Reinsurance Contracts
On November 11, 2024, James River Group Holdings, Ltd. (“Company”) entered into several significant agreements as disclosed in a recent 8-K filing with the Securities and Exchange Commission. One of the key agreements... More of this article »
Desjardins Weighs in on Candente Copper FY2024 Earnings
Candente Copper Corp. (TSE:DNT – Free Report) – Investment analysts at Desjardins issued their FY2024 earnings estimates for shares of Candente Copper in a research report issued to clients and investors on Tuesday,... More of this article »
Stifel Canada Estimates Candente Copper FY2024 Earnings
Candente Copper Corp. (TSE:DNT – Free Report) – Investment analysts at Stifel Canada issued their FY2024 earnings per share estimates for shares of Candente Copper in a research report issued on Tuesday, November 12th.... More of this article »
Aytu BioPharma Announces Fiscal 2025 First Quarter Results and CFO Transition
On November 11, 2024, Aytu BioPharma, Inc. (NASDAQ: AYTU) released its fiscal 2025 first-quarter operational and financial results through a press release. This announcement was followed by the scheduling of a conference call and... More of this article »
FY2024 Earnings Estimate for Savara Issued By HC Wainwright
Savara Inc (NASDAQ:SVRA – Free Report) – HC Wainwright boosted their FY2024 earnings per share estimates for Savara in a research note issued on Wednesday, November 13th. HC Wainwright analyst A. Fein now expects that... More of this article »
Veradigm Inc. Reports Financial Details in Recent 8-K Filing
Veradigm Inc., as reported in a recent 8-K filing with the Securities and Exchange Commission dated November 13, 2024, disclosed various financial details regarding its operations. The company, incorporated in Delaware, revealed that... More of this article »
Immunome Inc. Announces Third Quarter 2024 Financial Results and Pipeline Progress
Immunome Inc. (NASDAQ: IMNM), a biotechnology company specializing in targeted oncology therapies, recently disclosed its financial outcomes for the third quarter concluded on September 30, 2024, along with updates on its business... More of this article »
American Rebel Holdings, Inc. Enters Purchase and Exchange Agreement and Issues Unregistered Securities |
American Rebel Holdings, Inc. (NASDAQ: AREB) recently disclosed the entry into a Purchase and Exchange Agreement with Altbanq Lending LLC and an investor. The agreement, concluded on November 11, 2024, involves the purchase of a portion... More of this article »
Vaxart, Inc. Reports Third Quarter 2024 Financial Results –
Vaxart, Inc., a Delaware-based company trading on the Nasdaq Capital Market under the symbol VXRT, has recently released its financial results for the quarter ending September 30, 2024. The company issued a press release pertaining... More of this article »
ProPhase Labs, Inc. Reports Financial Results and Strategic DevelopmentsProPhase Labs, Inc. (NASDAQ: PRPH) recently disclosed its financial performance for the quarter ending September 30, 2024, through a press release. In an announcement dated Novem
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read ProPhase Labs’s 8K filing here. About ProPhase Labs (Get Free Report) ProPhase... More of this article »
Thoughtworks Holding, Inc. Completes Merger with Tasmania Merger Sub, Inc.
Thoughtworks Holding, Inc. (NASDAQ:TWKS) recently finalized its merger with Tasmania Merger Sub, Inc., according to an 8-K form filed with the Securities and Exchange Commission on November 13, 2024. The merger, as detailed in the... More of this article »
StockNews.com Upgrades Safety Insurance Group (NASDAQ:SAFT) to “Buy”
Safety Insurance Group (NASDAQ:SAFT – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a report released on Thursday. Safety Insurance Group Trading... More of this article »
Omeros Corporation (NASDAQ: OMER) Issues Press Release Announcing Financial Results for Q3 2024
Omeros Corporation, a biopharmaceutical company based in Seattle, Washington, released a press statement on November 13, 2024, disclosing its financial outcomes for the three and nine months ended September 30, 2024. The full details... More of this article »
Abeona Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
Abeona Therapeutics Inc. (NASDAQ: ABEO) recently released its financial results for the third quarter of 2024 along with notable corporate updates. The company’s key focus has been on the progress of its Biologics License Application... More of this article »
Pioneer Power Solutions Declares Special Dividend and Reports Financial Results
Pioneer Power Solutions, Inc. (NASDAQ: PPSI) recently announced its financial results for the third quarter that ended on September 30, 2024. The company issued a press release on November 14, 2024, highlighting its performance and... More of this article »
Evolution Metals LLC, Welsbach Technology Metals Acquisition Corp. Announce Merger Agreement, Name Change to New EM
Welsbach Technology Metals Acquisition Corp. (NASDAQ: WTMA) made a significant announcement today regarding the execution of an Amended and Restated Agreement and Plan of Merger dated November 6, 2024. The Merger Agreement involves... More of this article »
Rivian Automotive (NASDAQ:RIVN) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says
Rivian Automotive (NASDAQ:RIVN – Get Free Report) had its price target lifted by equities researchers at The Goldman Sachs Group from $10.00 to $12.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage... More of this article »
IMAC Holdings, Inc. Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1)
IMAC Holdings, Inc. (NASDAQ: BACK) recently disclosed that the company has been granted an extension by The Nasdaq Stock Market LLC (“Nasdaq”) to facilitate compliance with Nasdaq Listing Rule 5250(c)(1). The decision... More of this article »
ASP Isotopes Enters Memorandum of Understanding with Necsa for Advanced Nuclear Fuel Production Collaboration
Washington, D.C., November 14, 2024 – ASP Isotopes Inc. (NASDAQ: ASPI) has recently disclosed a significant strategic development. The company announced that it has entered into a Memorandum of Understanding (MOU) with The South... More of this article »
FitLife Brands, Inc. Announces Financial Results for Quarter Ended September 30, 2024
FitLife Brands, Inc. (NASDAQ: FTLF) recently released its financial results for the quarter that concluded on September 30, 2024. The company issued a press release on November 14, 2024, detailing the outcomes. FitLife Brands’... More of this article »
ABVC BioPharma Inc. Reports Operational Profit and Income Growth in Q3 2024
ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company focusing on therapeutic solutions in oncology/hematology, CNS, and ophthalmology, has announced its financial results and key operational achievements... More of this article »
SigmaTron International, Inc. Announces Departure and Appointment of Chief Financial OfficerUNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549_______________FORM 8-K_______________CURRENT REPORTPursuant to Section 13 or 15(d) of t
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read SigmaTron International’s 8K filing here. SigmaTron International Company Profile ... More of this article »
Grid Dynamics Holdings, Inc. Announces Pricing of Public OfferingSAN RAMON, Calif. – November 12, 2024 – Grid Dynamics Holdings, Inc. (NASDAQ:GDYN) disclosed on Friday that it has entered into an underwriting agreement with J.P. Morgan Securities LLC
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Grid Dynamics’s 8K filing here. About Grid Dynamics (Get Free Report) Grid... More of this article »
Tapestry Terminates Merger Agreement with Capri Holdings Limited
On November 13, 2024, Tapestry, Inc. (NYSE: TPR), a renowned house of iconic accessories and lifestyle brands, announced the termination of its merger agreement with Capri Holdings Limited. This decision comes after both companies... More of this article »
Regeneron Pharmaceuticals (NASDAQ:REGN) Coverage Initiated at Citigroup
Citigroup assumed coverage on shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) in a research report issued on Thursday, MarketBeat.com reports. The brokerage set a “neutral” rating and a $895.00... More of this article »
Northcoast Research Downgrades Jack in the Box (NASDAQ:JACK) to Neutral
Jack in the Box (NASDAQ:JACK – Get Free Report) was downgraded by equities research analysts at Northcoast Research from a “buy” rating to a “neutral” rating in a research report issued on Thursday, MarketBeat.com... More of this article »
Protalix BioTherapeutics Reports Positive Third Quarter 2024 Financial Results and Business Update
Protalix BioTherapeutics, Inc. (NYSE: PLX), a biopharmaceutical company specializing in the development, production, and commercialization of recombinant therapeutic proteins, recently disclosed its financial outcomes for the fiscal... More of this article »
Wolfe Research Begins Coverage on Maravai LifeSciences (NASDAQ:MRVI)
Investment analysts at Wolfe Research started coverage on shares of Maravai LifeSciences (NASDAQ:MRVI – Get Free Report) in a note issued to investors on Thursday, Marketbeat Ratings reports. The firm set a “peer perform”... More of this article »
Poseida Therapeutics Provides Update on Cell Therapy Research ProgramsOn November 14, 2024, Poseida Therapeutics, Inc. issued a press release providing an update on its cell therapy research and development programs. Members of the management team di
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Poseida Therapeutics’s 8K filing here. Poseida Therapeutics Company Profile ... More of this article »
StockNews.com Upgrades Primo Water (NYSE:PRMW) to Buy
Primo Water (NYSE:PRMW – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Thursday. A... More of this article »
StockNews.com Begins Coverage on Athersys (NASDAQ:ATHX)
Analysts at StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research note issued to investors on Thursday. The firm set a “hold” rating on the biopharmaceutical company’s... More of this article »
RenovoRx Reports Third Quarter 2024 Financial Results and Operational HighlightsUnited States Securities and Exchange Commission – Washington, D.C. 20549RenovoRx, Inc., a company specializing in novel targeted oncology therapies, recently announced i
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read RenovoRx’s 8K filing here. About RenovoRx (Get Free Report) RenovoRx, Inc,... More of this article »
Vertex Pharmaceuticals (NASDAQ:VRTX) Coverage Initiated at Citigroup
Equities researchers at Citigroup began coverage on shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) in a report released on Thursday, Marketbeat.com reports. The brokerage set a “buy” rating and a... More of this article »
Mizuho Downgrades Realty Income (NYSE:O) to Neutral
Realty Income (NYSE:O – Get Free Report) was downgraded by Mizuho from an “outperform” rating to a “neutral” rating in a report issued on Thursday, MarketBeat reports. They presently have a $60.00 price... More of this article »
Vail Resorts (NYSE:MTN) Coverage Initiated at UBS Group
UBS Group started coverage on shares of Vail Resorts (NYSE:MTN – Get Free Report) in a research note issued to investors on Thursday, MarketBeat reports. The firm set a “neutral” rating and a $185.00 price target... More of this article »
Piper Sandler Downgrades Kronos Bio (NASDAQ:KRON) to Neutral
Kronos Bio (NASDAQ:KRON – Get Free Report) was downgraded by equities research analysts at Piper Sandler from an “overweight” rating to a “neutral” rating in a report issued on Thursday, Marketbeat Ratings... More of this article »
JPMorgan Chase & Co. Downgrades Grupo Televisa, S.A.B. (NYSE:TV) to Neutral
Grupo Televisa, S.A.B. (NYSE:TV – Get Free Report) was downgraded by stock analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a research note issued to investors... More of this article »
Intellinetics, Inc. Reports 8.0% Revenue Growth for Third Quarter of 2024
Intellinetics, Inc., a digital transformation solutions provider, recently released its financial results for the fiscal quarter ended September 30, 2024. The company reported a total revenue increase of 8.0% over the same period... More of this article »
Cantor Fitzgerald Forecasts Strong Price Appreciation for Rocket Lab USA (NASDAQ:RKLB) Stock
Rocket Lab USA (NASDAQ:RKLB – Get Free Report) had its target price increased by investment analysts at Cantor Fitzgerald from $7.00 to $24.00 in a research note issued on Thursday,Benzinga reports. The brokerage currently has... More of this article »
Turning Point Brands (NYSE:TPB) Coverage Initiated at Oppenheimer
Investment analysts at Oppenheimer initiated coverage on shares of Turning Point Brands (NYSE:TPB – Get Free Report) in a report released on Thursday, MarketBeat.com reports. The brokerage set an “outperform” rating... More of this article »
National Research Corporation Announces Retirement of Principal Financial Officer and Secretary Linda Stacy
National Research Corporation (NASDAQ:NRC) disclosed in a recent filing with the Securities and Exchange Commission that Linda Stacy, the Secretary, Principal Financial Officer, and Principal Accounting Officer, has decided to retire... More of this article »
Ovintiv Acquires Montney Assets and Divests Uinta PropertiesOn November 13, 2024, Ovintiv Inc. (“Ovintiv”) made significant strategic moves in its portfolio by entering into an Agreement of Purchase and Sale with Paramount Resources Ltd. to acquire u
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Ovintiv’s 8K filing here. Ovintiv Company Profile (Get Free Report) Ovintiv... More of this article »
**Ocular Therapeutix, Inc. Announces Third Quarter 2024 Financial Results and Business Highlights** **
** Ocular Therapeutix, Inc. (NASDAQ: OCUL) recently released its financial results for the quarter ended September 30, 2024. The company reported total net revenue of $15.4 million for the third quarter, reflecting a 2.3% increase... More of this article »